Distinguished in Infant Respiratory Distress Syndrome

Dr. Ronald J. Wapner

Medical Genetics | Neonatology | Obstetrics and Gynecology
161 Fort Washington Ave, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Infant Respiratory Distress Syndrome
161 Fort Washington Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ronald Wapner is a Medical Genetics specialist and a Neonatologist in New York, New York. Dr. Wapner is rated as a Distinguished provider by MediFind in the treatment of Infant Respiratory Distress Syndrome. His top areas of expertise are Preeclampsia, High Blood Pressure in Infants, Gestational Diabetes, Chromosome 13q Duplication, and Hysterectomy.

His clinical research consists of co-authoring 415 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Infant Respiratory Distress Syndrome.

Specialties
Medical Genetics
Neonatology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

161 Fort Washington Ave, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
Enrollment Status: Recruiting
Publish Date: February 17, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk Women
A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk Women
Enrollment Status: Terminated
Publish Date: December 23, 2025
Intervention Type: Other, Drug
Study Drug: Pravastatin
Study Phase: Phase 3
A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug, Device
Study Phase: Phase 3
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Diagnostic test
An Observational Study of Hepatitis C Virus in Pregnancy
An Observational Study of Hepatitis C Virus in Pregnancy
Enrollment Status: Completed
Publish Date: February 05, 2024
Prescription After Cesarean Trial
Prescription After Cesarean Trial
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
Enrollment Status: Terminated
Publish Date: June 22, 2023
Intervention Type: Device
Study Phase: Phase 3
Maternal Morbidity and Mortality During the COVID-19 Pandemic
Maternal Morbidity and Mortality During the COVID-19 Pandemic
Enrollment Status: Completed
Publish Date: March 27, 2023
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Other, Drug
Study Drug: Cytomegalovirus Hyperimmune Globulin
Study Phase: Phase 3
Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preeclampsia With Severe Features and/or Fetal Growth Restriction in Support of a Molecular Assay Development
Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preeclampsia With Severe Features and/or Fetal Growth Restriction in Support of a Molecular Assay Development
Enrollment Status: Completed
Publish Date: April 29, 2022
SNP-based Microdeletion and Aneuploidy RegisTry
SNP-based Microdeletion and Aneuploidy RegisTry
Enrollment Status: Completed
Publish Date: January 29, 2021
Development of Non-invasive Prenatal Diagnostic Test for Microdeletion/Microduplication and Other Genetic Disorders Based on Fetal DNA Isolated From Maternal Blood
Development of Non-invasive Prenatal Diagnostic Test for Microdeletion/Microduplication and Other Genetic Disorders Based on Fetal DNA Isolated From Maternal Blood
Enrollment Status: Completed
Publish Date: December 30, 2020
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Enrollment Status: Unknown
Publish Date: January 23, 2020
Intervention Type: Other
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis: Follow-Up
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis: Follow-Up
Enrollment Status: Completed
Publish Date: March 25, 2019
Intervention Type: Other
Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial
Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 21, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 15 Less Clinical Trials

418 Total Publications

Visionary AI: Decoding Systemic Vascular Health and Hypertensive Disorders in Pregnancy Through Retinal Imaging and Artificial Intelligence.
Visionary AI: Decoding Systemic Vascular Health and Hypertensive Disorders in Pregnancy Through Retinal Imaging and Artificial Intelligence.
Journal: medRxiv : the preprint server for health sciences
Published: December 08, 2025
Similar Doctors
Distinguished in Infant Respiratory Distress Syndrome
Dr. Cynthia Gyamfi
Neonatology | Obstetrics and Gynecology
Distinguished in Infant Respiratory Distress Syndrome
Dr. Cynthia Gyamfi
Neonatology | Obstetrics and Gynecology

Office

51 W 51st St Ste 320, 
New York, NY 
 (5.6 miles away)
212-326-8951
Languages Spoken:
English
See accepted insurances

Cynthia Gyamfi is a Neonatologist and an Obstetrics and Gynecologist in New York, New York. Dr. Gyamfi is rated as a Distinguished provider by MediFind in the treatment of Infant Respiratory Distress Syndrome. Her top areas of expertise are Neonatal Sepsis, Newborn Transient Tachypnea, Infant Respiratory Distress Syndrome, Preeclampsia, and Hysterectomy.

Vineet Bhandari
Distinguished in Infant Respiratory Distress Syndrome
Dr. Vineet Bhandari
Neonatology | Pediatrics
Distinguished in Infant Respiratory Distress Syndrome
Dr. Vineet Bhandari
Neonatology | Pediatrics
20 York St, Yale- New Haven Children's Hospital-WP-2nd Floor, 
New Haven, CT 
 (61.5 miles away)
203-688-2320
Languages Spoken:
English
See accepted insurances

Vineet Bhandari is a Neonatologist and a Pediatrics provider in New Haven, Connecticut. Dr. Bhandari is rated as a Distinguished provider by MediFind in the treatment of Infant Respiratory Distress Syndrome. His top areas of expertise are Bronchopulmonary Dysplasia, Premature Infant, Necrotizing Enterocolitis, and Neonatal Sepsis.

Distinguished in Infant Respiratory Distress Syndrome
Dr. Uma Reddy
Neonatology | Obstetrics and Gynecology
Distinguished in Infant Respiratory Distress Syndrome
Dr. Uma Reddy
Neonatology | Obstetrics and Gynecology

CUIMC/Herbert Irving Pavilion

161 Fort Washington Ave, 
New York, NY 
 (0.1 miles away)
212-305-7334
Languages Spoken:
English
See accepted insurances

Uma Reddy is a Neonatologist and an Obstetrics and Gynecologist in New York, New York. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Infant Respiratory Distress Syndrome. Her top areas of expertise are Gestational Diabetes, Newborn Transient Tachypnea, Placental Insufficiency, High Blood Pressure in Infants, and Hysterectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wapner's expertise for a condition
ConditionClose
View All 20 Advanced Conditions
View All 48 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile